Geriatric Medicines Market, Global Outlook and Forecast 2024-2030
Report ID
47040
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
109
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Geriatric Medicines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Geriatric Medicines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Geriatric Medicines, challenges faced by the industry, and potential opportunities for market players.
The global Geriatric Medicines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Geriatric Medicines market presents opportunities for various stakeholders, including Cardiovascular diseases, Arthritis. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Geriatric Medicines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Geriatric Medicines market was valued at US$ 671970 million in 2023 and is projected to reach US$ 1108100 million by 2030, at a CAGR of 7.5% during the forecast period.
The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.
Key Features:
The research report on the Geriatric Medicines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Geriatric Medicines market.
Market Overview: The report provides a comprehensive overview of the Geriatric Medicines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Analgesics, Antihypertensives), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Geriatric Medicines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Geriatric Medicines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Geriatric Medicines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Geriatric Medicines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Geriatric Medicines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Geriatric Medicines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Geriatric Medicines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Geriatric Medicines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Geriatric Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
    Analgesics
    Antihypertensives
    Statins
    Antidiabetics
    Proton Pump Inhibitor
    Anticoagulant
    Antipsychotics
    Antidepressants
Market segment by Application
    Cardiovascular diseases
    Arthritis
    Neurological Disorders
    Cancer
    Osteoporosis
    Respiratory
    Other
Global Geriatric Medicines Market Segment Percentages, By Region and Country, 2023 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Eli Lilly and Company
    AstraZeneca
    Boehringer Ingelheim
    Abbott Laboratories
    Sanofi
    Bristol-Myers Squibb
    Merck
    Novartis
    Pfizer
    GSK
Outline of Major Chapters:
Chapter 1: Introduces the definition of Geriatric Medicines, market overview.
Chapter 2: Global Geriatric Medicines market size in revenue.
Chapter 3: Detailed analysis of Geriatric Medicines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Geriatric Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 Geriatric Medicines Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Geriatric Medicines Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Geriatric Medicines Overall Market Size
    2.1 Global Geriatric Medicines Market Size: 2023 VS 2030
    2.2 Global Geriatric Medicines Market Size, Prospects & Forecasts: 2019-2030
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Geriatric Medicines Players in Global Market
    3.2 Top Global Geriatric Medicines Companies Ranked by Revenue
    3.3 Global Geriatric Medicines Revenue by Companies
    3.4 Top 3 and Top 5 Geriatric Medicines Companies in Global Market, by Revenue in 2023
    3.5 Global Companies Geriatric Medicines Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Geriatric Medicines Players in Global Market
        3.6.1 List of Global Tier 1 Geriatric Medicines Companies
        3.6.2 List of Global Tier 2 and Tier 3 Geriatric Medicines Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Geriatric Medicines Market Size Markets, 2023 & 2030
        4.1.2 Analgesics
        4.1.3 Antihypertensives
        4.1.4 Statins
        4.1.5 Antidiabetics
        4.1.6 Proton Pump Inhibitor
        4.1.7 Anticoagulant
        4.1.8 Antipsychotics
        4.1.9 Antidepressants
    4.2 By Type - Global Geriatric Medicines Revenue & Forecasts
        4.2.1 By Type - Global Geriatric Medicines Revenue, 2019-2024
        4.2.2 By Type - Global Geriatric Medicines Revenue, 2025-2030
        4.2.3 By Type - Global Geriatric Medicines Revenue Market Share, 2019-2030
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Geriatric Medicines Market Size, 2023 & 2030
        5.1.2 Cardiovascular diseases
        5.1.3 Arthritis
        5.1.4 Neurological Disorders
        5.1.5 Cancer
        5.1.6 Osteoporosis
        5.1.7 Respiratory
        5.1.8 Other
    5.2 By Application - Global Geriatric Medicines Revenue & Forecasts
        5.2.1 By Application - Global Geriatric Medicines Revenue, 2019-2024
        5.2.2 By Application - Global Geriatric Medicines Revenue, 2025-2030
        5.2.3 By Application - Global Geriatric Medicines Revenue Market Share, 2019-2030
6 Sights by Region
    6.1 By Region - Global Geriatric Medicines Market Size, 2023 & 2030
    6.2 By Region - Global Geriatric Medicines Revenue & Forecasts
        6.2.1 By Region - Global Geriatric Medicines Revenue, 2019-2024
        6.2.2 By Region - Global Geriatric Medicines Revenue, 2025-2030
        6.2.3 By Region - Global Geriatric Medicines Revenue Market Share, 2019-2030
    6.3 North America
        6.3.1 By Country - North America Geriatric Medicines Revenue, 2019-2030
        6.3.2 US Geriatric Medicines Market Size, 2019-2030
        6.3.3 Canada Geriatric Medicines Market Size, 2019-2030
        6.3.4 Mexico Geriatric Medicines Market Size, 2019-2030
    6.4 Europe
        6.4.1 By Country - Europe Geriatric Medicines Revenue, 2019-2030
        6.4.2 Germany Geriatric Medicines Market Size, 2019-2030
        6.4.3 France Geriatric Medicines Market Size, 2019-2030
        6.4.4 U.K. Geriatric Medicines Market Size, 2019-2030
        6.4.5 Italy Geriatric Medicines Market Size, 2019-2030
        6.4.6 Russia Geriatric Medicines Market Size, 2019-2030
        6.4.7 Nordic Countries Geriatric Medicines Market Size, 2019-2030
        6.4.8 Benelux Geriatric Medicines Market Size, 2019-2030
    6.5 Asia
        6.5.1 By Region - Asia Geriatric Medicines Revenue, 2019-2030
        6.5.2 China Geriatric Medicines Market Size, 2019-2030
        6.5.3 Japan Geriatric Medicines Market Size, 2019-2030
        6.5.4 South Korea Geriatric Medicines Market Size, 2019-2030
        6.5.5 Southeast Asia Geriatric Medicines Market Size, 2019-2030
        6.5.6 India Geriatric Medicines Market Size, 2019-2030
    6.6 South America
        6.6.1 By Country - South America Geriatric Medicines Revenue, 2019-2030
        6.6.2 Brazil Geriatric Medicines Market Size, 2019-2030
        6.6.3 Argentina Geriatric Medicines Market Size, 2019-2030
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Geriatric Medicines Revenue, 2019-2030
        6.7.2 Turkey Geriatric Medicines Market Size, 2019-2030
        6.7.3 Israel Geriatric Medicines Market Size, 2019-2030
        6.7.4 Saudi Arabia Geriatric Medicines Market Size, 2019-2030
        6.7.5 UAE Geriatric Medicines Market Size, 2019-2030
7 Geriatric Medicines Companies Profiles
    7.1 Eli Lilly and Company
        7.1.1 Eli Lilly and Company Company Summary
        7.1.2 Eli Lilly and Company Business Overview
        7.1.3 Eli Lilly and Company Geriatric Medicines Major Product Offerings
        7.1.4 Eli Lilly and Company Geriatric Medicines Revenue in Global Market (2019-2024)
        7.1.5 Eli Lilly and Company Key News & Latest Developments
    7.2 AstraZeneca
        7.2.1 AstraZeneca Company Summary
        7.2.2 AstraZeneca Business Overview
        7.2.3 AstraZeneca Geriatric Medicines Major Product Offerings
        7.2.4 AstraZeneca Geriatric Medicines Revenue in Global Market (2019-2024)
        7.2.5 AstraZeneca Key News & Latest Developments
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Company Summary
        7.3.2 Boehringer Ingelheim Business Overview
        7.3.3 Boehringer Ingelheim Geriatric Medicines Major Product Offerings
        7.3.4 Boehringer Ingelheim Geriatric Medicines Revenue in Global Market (2019-2024)
        7.3.5 Boehringer Ingelheim Key News & Latest Developments
    7.4 Abbott Laboratories
        7.4.1 Abbott Laboratories Company Summary
        7.4.2 Abbott Laboratories Business Overview
        7.4.3 Abbott Laboratories Geriatric Medicines Major Product Offerings
        7.4.4 Abbott Laboratories Geriatric Medicines Revenue in Global Market (2019-2024)
        7.4.5 Abbott Laboratories Key News & Latest Developments
    7.5 Sanofi
        7.5.1 Sanofi Company Summary
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Geriatric Medicines Major Product Offerings
        7.5.4 Sanofi Geriatric Medicines Revenue in Global Market (2019-2024)
        7.5.5 Sanofi Key News & Latest Developments
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Company Summary
        7.6.2 Bristol-Myers Squibb Business Overview
        7.6.3 Bristol-Myers Squibb Geriatric Medicines Major Product Offerings
        7.6.4 Bristol-Myers Squibb Geriatric Medicines Revenue in Global Market (2019-2024)
        7.6.5 Bristol-Myers Squibb Key News & Latest Developments
    7.7 Merck
        7.7.1 Merck Company Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Geriatric Medicines Major Product Offerings
        7.7.4 Merck Geriatric Medicines Revenue in Global Market (2019-2024)
        7.7.5 Merck Key News & Latest Developments
    7.8 Novartis
        7.8.1 Novartis Company Summary
        7.8.2 Novartis Business Overview
        7.8.3 Novartis Geriatric Medicines Major Product Offerings
        7.8.4 Novartis Geriatric Medicines Revenue in Global Market (2019-2024)
        7.8.5 Novartis Key News & Latest Developments
    7.9 Pfizer
        7.9.1 Pfizer Company Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Geriatric Medicines Major Product Offerings
        7.9.4 Pfizer Geriatric Medicines Revenue in Global Market (2019-2024)
        7.9.5 Pfizer Key News & Latest Developments
    7.10 GSK
        7.10.1 GSK Company Summary
        7.10.2 GSK Business Overview
        7.10.3 GSK Geriatric Medicines Major Product Offerings
        7.10.4 GSK Geriatric Medicines Revenue in Global Market (2019-2024)
        7.10.5 GSK Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us